who owns compass pathways ?

Description

https://www.wallstreetzen.com › stocks › us › nasdaq › cmps › ownership

https://www.wallstreetzen.com › stocks › us › nasdaq › cmps › ownership
Compass Pathways Stock Ownership – Who Owns Compass Pathways in 2022 …
Compass Pathways (NASDAQ: CMPS) is owned by 17.54% institutional shareholders, 63.11% Compass Pathways insiders, and 19.35% retail investors. Life Sciences Nv Atai is the largest individual Compass Pathways shareholder, owning 9.57M shares representing 22.47% of the company. Life Sciences Nv Atai’s Compass Pathways shares are currently valued at $80.83M.

https://compasspathways.com

https://compasspathways.com
COMPASS Pathways | Mental Health Care Company
We are COMPASS Pathways, a mental health care company dedicated to accelerating patient access to evidence-based innovation in mental health. News & events. News releases; Events; Presentations; SEC filings & annual reports; Our annual review; Stock information. Stock quote & chart; Historical price lookup; Analyst Coverage; Split history; Corporate governance
About usOur researchOur teamJoin usNews & viewsInvestors

https://compasspathways.com › psilocybin-therapy-216-patients

https://compasspathways.com › psilocybin-therapy-216-patients
COMPASS Pathways: COMP360 Psilocybin therapy administration completed
George Goldsmith, CEO and Co-founder, COMPASS Pathways, said, Completing recruitment to our trial is a tremendous milestone and a huge step forward towards our goal of getting psilocybin therapy to patients in need. We are fortunate to be doing this in collaboration with hundreds of talented and dedicated people from our 22 trial sites in 10 countries – including investigators, raters, study coordinators and nurses, therapists, and pharmacists – as well as our supply chain …

https://www.crunchbase.com › organization › compass-pathways

https://www.crunchbase.com › organization › compass-pathways
COMPASS Pathways – Crunchbase Company Profile & Funding
Compass Pathways is a mental health care company dedicated to accelerating patient access to evidence-based innovation in mental health. It is conducting a large-scale psilocybin therapy clinical trial, in 20 sites across nine countries in Europe and North America. It was founded in 2016 and is based in Altrincham, Cheshire. Lists Featuring This Company. Edit Lists Featuring This Company …

https://www.nasdaq.com › articles › how-much-of-compass-pathways-plc-nasdaq:cmps-do-insiders-own-2021-04-12

https://www.nasdaq.com › articles › how-much-of-compass-pathways-plc-nasdaq:cmps-do-insiders-own-2021-04-12
How Much Of COMPASS Pathways plc (NASDAQ:CMPS) Do Insiders Own?
COMPASS Pathways is not owned by hedge funds. Our data shows that ATAI Life Sciences AG is the largest shareholder with 22% of shares outstanding. The second and third largest shareholders are…

https://stockzoa.com › ticker › cmps

https://stockzoa.com › ticker › cmps
Who owns COMPASS PATHWAYS PLC? – stockzoa
Top stakeholders of CMPS according to 13F filings – stockzoa Who owns COMPASS PATHWAYS PLC? Add alert for CMPS Ticker: CMPS CUSIP Number: 20451w101 Tip: Access positions for across all investors Analyze quarterly positions in Compass Pathways with up to 7 years of data, all consolidated into one spreadsheet Download as csv Download as Excel

https://www.crunchbase.com › organization › compass-pathways › company_financials

https://www.crunchbase.com › organization › compass-pathways › company_financials
COMPASS Pathways – Funding, Financials, Valuation & Investors – Crunchbase
COMPASS Pathways is funded by 11 investors. Perceptive Advisors and Camden Partners are the most recent investors. Funding Rounds Number of Funding Rounds 4 Total Funding Amount $116.2M COMPASS Pathways has raised a total of $116.2M in funding over 4 rounds. Their latest funding was raised on Apr 27, 2020 from a Series B round.

https://finance.yahoo.com › news › compass-pathways-plcs-nasdaq-cmps-062037169.html

https://finance.yahoo.com › news › compass-pathways-plcs-nasdaq-cmps-062037169.html
Is COMPASS Pathways plc’s (NASDAQ:CMPS) Shareholder Ownership … – Yahoo!
COMPASS Pathways is not owned by hedge funds. The company’s largest shareholder is Atai Life Sciences B.V., with ownership of 20%. The second and third largest shareholders are Ekaterina…

https://seekingalpha.com › article › 4390988-compass-pathways-overvalued-psychedelic-company-single-mediocre-drug

https://seekingalpha.com › article › 4390988-compass-pathways-overvalued-psychedelic-company-single-mediocre-drug
Compass Pathways: An Overvalued Psychedelic Company With A Single …
COMPASS Pathways (NASDAQ:CMPS) is a London-based psychedelic drug company advancing a single pipeline candidate for treatment-resistant depression (TRD). CMPS filed an IPO on September 18, 2020 …

https://seekingalpha.com › article › 4395315-compass-pathways-risky-and-overvalued

https://seekingalpha.com › article › 4395315-compass-pathways-risky-and-overvalued
Compass Pathways: Risky And Overvalued (NASDAQ:CMPS)
Compass Pathways is a biotech psychedelic medicine development and therapy company that has developed a synthetic formulation of psilocybin, COMP360, for combatting treatment-resistant depression.

lesoutrali bot